About Hims & Hers Health, Inc. 
Hims & Hers Health, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 88 Schemes (52.24%)
Foreign Institutions
Held by 192 Foreign Institutions (11.8%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
618 Million
(Quarterly Results - Dec 2025)
Net Profit:
21 Million
Pharmaceuticals & Biotechnology
USD 5,671 Million (Small Cap)
36.00
NA
0.00%
0.59
27.23%
9.76






